JNJ-75105186

· Janssen Pharmaceutical K.K.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for JNJ-75105186, covering 2025-02-03 to 2025-02-03. Get the full timeline:

Most recent: Clinical Trial Update: A Study of JNJ-75105186 in Healthy Japanese and Chinese Participants [Phase 1]